Electrolyte and Fluid Disturbances in Subarachnoid Hemorrhage and Traumatic Brain Injury
NCT ID: NCT01313975
Last Updated: 2013-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
85 participants
OBSERVATIONAL
2011-01-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this observational study is to systematically analyze the incidence, characteristics, potential diagnostic markers and predisposing factors of such disturbances. The investigators hypothesize that many disturbances cannot be classified with a standard diagnostic approach and that variable fluid management contributes to their pathophysiology.
Patients will be closely monitored clinically and the exact fluid and electrolyte balances will be recorded. Treatment decisions are within the bedside physicians responsibility. Baseline fluid management is standardised. No interventions are planned. The observation period equal the duration of ICU stay.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Changes in CSF Ionic Composition After Aneurysmal Meningeal Hemorrhage
NCT05942755
Prevalence, Severity, Risk Factors, and Prognostic Value of Hyponatremia in Patients With Traumatic Brain Injury
NCT05301049
A Low ChloridE hyperTonic Solution for Brain Edema
NCT03204955
Early Induced Hypernatremia for the Prevention and Management of Brain Edema
NCT02798601
Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury
NCT01605357
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Electrolyte disturbances and fluid shifts are common in patients with subarachnoid hemorrhage (SAH) or traumatic brain injury (TBI). They usually have a rapid onset with impact on morbidity (possibly mortality) and length of stay. So far the understanding of underlying pathophysiologies and the contribution of iatrogenic influences is not fully understood.
Only limited evidence and data on classification, management and outcome of patients exists.
Objective
To describe the incidence, characteristics and duration of sodium and fluid disturbances in patients with SAH or TBI.
To document exact fluid and electrolyte management To evaluate predisposing factors and potential predicting biomarkers such as natriuretic peptides, renin-aldosterone system.
Methods
Prospective systematic observational study with 50 patients in the SAH group and 50 patients in the TBI group.
8hourly clinical assessment, blood and urin samples. Defined trigger points for additional measurements.
Continuous fluid balance documentation Daily measurement of natriuretic peptides, aldosterone and renin
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Patients with non-traumatic subarachnoid hemorrhage
No interventions assigned to this group
2
Patients with severe traumatic brain injury
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* severe traumatic brain injury (GCS\<9)
Exclusion Criteria
* time to admission after injury or bleed more than 7days
* death expected in less than 12hours
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Foundation for research in Anaesthesie and Intensive Care Medicine
UNKNOWN
Brahms AG
INDUSTRY
Insel Gruppe AG, University Hospital Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Intensive Care Medicine University Hospital Bern, Switzerland
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jan Wiegand, MD
Role: PRINCIPAL_INVESTIGATOR
Dep. Intensive Care Medicine, University Hospitals Bern
Stephan Jakob, MD, PhD
Role: STUDY_DIRECTOR
Dep. Intensive Care Medicine, University Hospitals Bern
Jukka Takala, MD PhD
Role: STUDY_CHAIR
Dep. Intensive Care Medicine, University Hospitals Bern
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dep. of Intensive Care Medicine Bern University Hospital
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
203/10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.